Duke University Medical Center
Durham, North Carolina, 27710, United States
NCT Number: NCT04329702
This is a pilot randomized clinical trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is designed to test the acceptability, feasibility, and clinical impact of a coping skills training intervention (Blueprint) delivered via a mobile app. This trial will allow us to determine if new changes to intervention delivery, inclusion criteria, and other factors are successful. It will also inform the development of a next-step efficacy focused trial.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Durham, North Carolina, 27710, United States
As survival has improved for the 2 million people with cardiorespiratory failure managed annually in US intensive care units (ICUs), research has clarified how these survivors suffer from severe and persistent symptoms of psychological distress-depression, anxiety, and post-traumatic stress disorder (PTSD)-after discharge. However, few interventions exist that are relevant to patients' experiences and that also accommodate their many physical, social, and financial barriers to personalized care. To fill this gap, we developed a telephone- and web-based coping skills training (CST) program.
CST is an empirically-supported psychosocial intervention that targets the use of the adaptive coping skills to decrease psychological distress and improve quality of life. We conducted a multicenter randomized clinical trial (RCT) called CSTEP that compared CST to an education program (EP) among a general sample of ICU survivors who received mechanical ventilation for cardiorespiratory failure. CST reduced depression symptoms and improved quality of life at 6 months in a pre-specified subgroup with elevated baseline distress. This RCT also identified key questions regarding best practices for identifying patients who are highly distressed yet whose physical illness is manageable, as well as delivering the intervention in a more convenient, and scalable manner. In a recent RCT testing a mindfulness intervention (LIFT), we found that a self-directed mobile app approach increased dose, adherence, and retention. However, many patients reported low enthusiasm for a meditation-based intervention.
What is needed before a second multicenter RCT is to apply the promising CST content to a LIFT-inspired mobile app-based delivery system, and then to test it within a targeted patient population with a high likelihood of response (i.e., high baseline psychological distress). Therefore, we propose a 2-year R34 mixed-methods project that includes a pilot RCT in which we will randomize 45 cardiorespiratory failure / insufficiency survivors to one of three arms in equal ratios: intervention plus therapist for non-responders (n ~15), intervention without a therapist (n ~15), and usual care control (n ~15). Randomization will be stratified by ICU service (medical vs. surgical), baseline HADS score (<14 vs. ≥14), and age (<50 vs. ≥50). Our specific aims will: (1) Optimize the usability of a self-directed mobile app (Blueprint) and an automated post-discharge distress screening system; (2) Test two promising iterations of Blueprint vs. usual care in a pilot 3-arm RCT with 3-month follow up, and (3) Explore facilitators and barriers to Blueprint implementation, using these data to inform any necessary final revisions to the Blueprint app.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
(in hospital):
Inclusion criteria
(post-discharge)
Exclusion criteria
(post-discharge)
The intervention is a mobile app that delivers a 4-week long program of coping skills training. The app contains video, visual, and text content and has a companion PDF workbook. It provides timeline-driven prompts to complete weekly tasks (e.g., viewing videos, completing surveys) and coaching participants to use their current stressors as context for real-life application of adaptive coping skills. A therapist will call participant to introduce the intervention and perform a brief relaxation exercise.
Other names: Blueprint; mobile coping skills training (mCST) plus therapist
The intervention is a mobile app that delivers a 4-week long program of coping skills training. The app contains video, visual, and text content and has a companion PDF workbook. It provides timeline-driven prompts to complete weekly tasks (e.g., viewing videos, completing surveys) and coaching participants to use their current stressors as context for real-life application of adaptive coping skills. App chat room access will be provided.
Other names: Blueprint; mobile coping skills training (mCST)
Time frame: Between baseline and 1 month post-randomization
Depression and anxiety symptoms. Scores range from 0 (better) to 42 (worse)
Time frame: Between baseline and 3 months post-randomization
Depression and anxiety symptoms. Scores range from 0 (better) to 42 (worse)
Time frame: Between baseline and 1 month post-randomization
Post-traumatic stress disorder symptoms. Scores can range from 10 (best) to 70 (worst).
Time frame: Between baseline and 3 months post-randomization
Post-traumatic stress disorder symptoms. Scores can range from 10 (best) to 70 (worst).
Time frame: 1 month post-randomization
A measure of acceptability. Scores can range from 5 (worst) to 35 (best)
Time frame: 1 month post-randomization
Measured by how many total tasks of the 33 possible that participants completed within the app during the intervention. Note that a value >33 indicates that participants completed more tasks than required.
Time frame: Between baseline and 1 month post-randomization
A measure of quality of life. Scores can range from 0 (worst) to 100 (best)
Time frame: Between baseline and 3 month post-randomization
A measure of quality of life. Scores can range from 0 (worst) to 100 (best)
Time frame: 1 month post-randomization
An adapted version of the PHQ-15; a measure of physical symptoms. Scores can range from 0 (best) to 30 (worst).
Time frame: 3 months post-randomization
An adapted version of the PHQ-15; a measure of physical symptoms. Scores can range from 0 (best) to 30 (worst).
Time frame: Between baseline and 1 month post-randomization
A visual analog scale appended to the HADS which allows participants to report how distressing they perceive the depression and anxiety symptoms to be that they reported in the HADS. Scores range from 0 (best) to 100 (worst)
Time frame: Between baseline and 3 months post-randomization
A visual analog scale appended to the HADS which allows participants to report how distressing they perceive the depression and anxiety symptoms to be that they reported in the HADS. Scores range from 0 (best) to 100 (worst)
Time frame: Between baseline and 1 month post-randomization
A visual analog scale appended to the PTSS which allows participants to report how distressing they perceive the depression and anxiety symptoms to be that they reported in the PTSS. Scores range from 0 (best) to 100 (worst)
Time frame: Between baseline and 3 months post-randomization
A visual analog scale appended to the PTSS which allows participants to report how distressing they perceive the depression and anxiety symptoms to be that they reported in the PTSS. Scores range from 0 (best) to 100 (worst)
Duke University
Other
Optimizing a Self-directed Mobile Coping Skills Training Intervention to Improve Cardiorespiratory Failure Survivors' Psychological Distress
Acronym: Blueprint
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04038567
Anxiety Disorders, Behavior
Aurora, Colorado, United States
View Trial DetailsNCT04581200
Anxiety Disorders, Behavior
Aurora, Colorado, United States
View Trial DetailsNCT05318482
Behavior, Cardiorespiratory Failure
Lumezzane, Brescia, Italy
View Trial DetailsNCT04921631
Anxiety Disorders, Behavior
Pittsburgh, Pennsylvania, United States
View Trial Details